Abstract
Dissatisfaction within the National Institutes of Health (NIH) is growing over the Bush Administration's restrictions on funding for work with human embryonic stem (ES) cells. Meanwhile, measures to loosen restrictions may finally make it to the floor this year in Congress.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
